Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beau R Webber

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Communications Biology|January 24, 2026
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpointsFlorencia Cano, Alberto Bravo-Blas, Mathilde Colombe, et al.
NPJ Regenerative Medicine|March 3, 2017
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosaBeau R Webber, Mark J Osborn, Amber N McElroy, et al.
Blood Advances|August 27, 2021
An irradiated marrow niche reveals a small noncollagenous protein mediator of homing, dermatopontinAshley C Kramer, Yuliana Astuti, Alexis Elfstrum, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base EditingMinjing Wang, Joshua B Krueger, Alexandria K Gilkey, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 12, 2017
Rapid generation of Col7a1<sup>-/-</sup> mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cellsBeau R Webber, Kyle T O'Connor, Ron T McElmurry, et al.
Frontiers in Immunology|March 27, 2026
Midgestational injection of highly expanded human CD34+ cells increases lineages of human immune cells and supports thymic development in <i>RAG2-/-IL2RG-/Y</i> SCID pigsAhlea M Forster, Amanda Ahrens Kress, Matti Kiupel, et al.
Nature Biomedical Engineering|December 13, 2023
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repairBeau R Webber, Matthew J Johnson, Joseph G Skeate, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine ProductionJames D Dahlvang, Jenna K Dick, Jules A Sangala, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Communications Biology|January 24, 2026
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpointsFlorencia Cano, Alberto Bravo-Blas, Mathilde Colombe, et al.
NPJ Regenerative Medicine|March 3, 2017
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosaBeau R Webber, Mark J Osborn, Amber N McElroy, et al.
Blood Advances|August 27, 2021
An irradiated marrow niche reveals a small noncollagenous protein mediator of homing, dermatopontinAshley C Kramer, Yuliana Astuti, Alexis Elfstrum, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base EditingMinjing Wang, Joshua B Krueger, Alexandria K Gilkey, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 12, 2017
Rapid generation of Col7a1<sup>-/-</sup> mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cellsBeau R Webber, Kyle T O'Connor, Ron T McElmurry, et al.
Frontiers in Immunology|March 27, 2026
Midgestational injection of highly expanded human CD34+ cells increases lineages of human immune cells and supports thymic development in <i>RAG2-/-IL2RG-/Y</i> SCID pigsAhlea M Forster, Amanda Ahrens Kress, Matti Kiupel, et al.
Nature Biomedical Engineering|December 13, 2023
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repairBeau R Webber, Matthew J Johnson, Joseph G Skeate, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine ProductionJames D Dahlvang, Jenna K Dick, Jules A Sangala, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Pageof 8